Our News on Newswise

‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers

A multi-disciplinary, “One Health” approach to cancer research is necessary to guide society in reduction of toxic substances, as well as regulation of chemical impacts on the environment and public health, according to an editorial published...
6-Jul-2022 5:05 PM EDT Add to Favorites

VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review

Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.
6-Jul-2022 3:45 PM EDT Add to Favorites

Drug Repurposing Identifies New Candidates to Treat Mesothelioma

A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).
28-Jun-2022 9:00 AM EDT Add to Favorites

Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology

There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.
27-Jun-2022 3:00 PM EDT Add to Favorites

Public Health Conference: 2022 Theme: Response to COVID-19 and Impact of the Pandemic

Public Health conference hosted by Temple University Rome and Temple College of Public Health.
9-May-2022 1:30 PM EDT Add to Favorites

Targeting Cervical Cancer Stem Cells to Improve Outcomes

The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
6-May-2022 10:35 AM EDT Add to Favorites

New Mesothelioma Drugs, Once Hailed as Gamechangers, Don’t Live Up to the Hype

Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mostly related to asbestos exposure whose incidence is constantly rising, especially in low-income countries.
10-Mar-2022 6:05 AM EST Add to Favorites

Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow

Recently approved drugs to boost the immune response against cancer represents a novelty that should not be over-hyped, researchers say
27-Dec-2021 5:05 PM EST Add to Favorites


See All News

Our Experts on Newswise

Precision Medicine and the Anti-Cancer Properties of Foods like Green Tea, SHRO Founder Comments

2-Mar-2021 8:15 AM EST

"We've got to get our act together" on public health measures to combat COVID, says Fauci

3-Nov-2020 2:35 PM EST

‘Genetic Shield’ May Explain Lower COVID Mortality in Southern Italy Compared to North

4-Jun-2020 9:55 AM EDT

Coronavirus: concern and precaution ok, but panic and hysteria unjustified, says expert

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
6-Mar-2020 8:20 AM EST

Cancer DNA Sequencing Has Potential, but Not a Magic Bullet, Says Expert

16-Jan-2018 11:05 AM EST

Newswise: Slide1.jpg

Thorough Genotyping and Repurposed Drugs Key to Treating Small-Cell Lung Cancer, says Cancer Expert

Cancer expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University, describes the recent progress and future possibilities of treating SCLC.
13-Apr-2017 7:05 AM EDT

Newswise: giordanoheadshot.png

Every Diagnosis of Cancer Should Come with One of These, Says Cancer Expert

“Every cancer diagnosis should come with a referral to genetic counseling,” says cancer expert Dr. Antonio Giordano, President of the Sbarro Health Research Organization at Temple University.
8-Feb-2017 10:30 AM EST

See All Experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.

Experts

Contacts

Barbara Colombo

barbaracolombo@ble-group.com

Antonio Giordano
President

president@shro.org

+1215-204-9520

James Vincenzo
Billing

jvincenzo@shro.org

Twitter

close
0.49709